Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Biocon Launches Denosumab Biosimilars Bosaya, Aukelso in US

Parthika Patel9 April 2026 8:33 PM IST

New Delhi: Biocon Limited has announced the commercial launch of its denosumab biosimilars, Bosaya and Aukelso, in the United States, marking a...

GPAT 2026 Results Declared, General Cut-Off at 96.25 Percentile, NBEMS Releases Rank Details

Parthika Patel9 April 2026 6:03 PM IST

New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has declared the Graduate Pharmacy Aptitude Test (GPAT) 2026 results, with...

Lupin, Zydus Secure USFDA Nod for Dapagliflozin Tablets

Parthika Patel9 April 2026 5:50 PM IST

New Delhi: Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration (USFDA) for...

Dr Reddy's Divests Svaas Wellness Stake to Enspirit for Rs 2.23 Crore

Parthika Patel8 April 2026 9:28 PM IST

Hyderabad: Drugmaker Dr. Reddy's Laboratories Limited has entered into an agreement to sell its entire shareholding in its wholly owned subsidiary,...

Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity

Parthika Patel8 April 2026 9:22 PM IST

New Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and...

USFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity

Parthika Patel8 April 2026 8:47 PM IST

New Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its...

Granules India's US Arm Gets 4 USFDA Observations

Parthika Patel7 April 2026 11:45 AM IST

New Delhi: Granules India Limited has announced that its US-based subsidiary, Granules Pharmaceuticals, Inc. (GPI), has successfully completed a...

Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal

Parthika Patel7 April 2026 11:15 AM IST

New Delhi: Zydus Wellness Limited has informed that its step-down wholly owned subsidiary, Comfort Click Limited (CCL), UK, has received a penalty...

Rajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active Ingredient

Parthika Patel7 April 2026 10:45 AM IST

New Delhi: Rajasthan drug control authorities have issued a statewide alert after laboratory tests found that a widely sold antibiotic, Qcepod 200,...

DCC Approves RealTime Digital Portal to Track NDPS Regulated Pharma Products

Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report

Parthika Patel6 April 2026 9:20 PM IST

New Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin,...

Aurobindo Pharma Transfers Domestic Branded Business to Auropharm for Rs 143.21 Crore

Parthika Patel6 April 2026 9:00 PM IST

New Delhi: Aurobindo Pharma Limited has approved the transfer of its domestic branded generic pharmaceutical formulations business to its wholly owned...

Sun Pharma Names Former PwC India COO Satyavati Berera as Independent Director

Parthika Patel6 April 2026 8:51 PM IST

New Delhi: Sun Pharmaceutical Industries Limited has approved the appointment of Satyavati Berera as an Independent Director on its Board for a term...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok